Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A practical comparison of retirement index funds and target date funds, outlining when each may be the smarter pick for different retirement goals.
26,044 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
As Zepp Health nears the release of its Q1 2026 earnings, investors want clarity on growth, margins, and strategic be...
If you’re hunting for value in the chip space, these undervalued semiconductor stocks investors can buy now offer sol...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
When headlines shout about dream finders homes struggles, investors should look past the noise and examine the fundam...
Snowflake’s stock dips after the company outlines a mixed outlook for 2026, signaling a slower path to profitability ...
Eli Lilly sits at the center of the healthcare toolkit for many investors. This article breaks down the case for and ...
PureCycle (PCT) is expanding its recycling footprint, and the Q4 2025 earnings call could reshape how investors value...
When a niche space-data stock jumps, investors want to know the real reasons behind the move. This guide explains why...
EOS Energy Enterprises sparked a notable move in today’s trading. This article breaks down the possible catalysts beh...
Stagwell stock surged today after the marketing firm issued a confident AI-powered growth forecast. This piece breaks...